Abstract
Background: Baveno VI criteria [platelet count (plt) >150 × 109/l and liver stiffness measurement (LSM) <20 KPa] to rule out high risk esophageal varices (HRV) in chronic advanced viral-related liver disease (cACLD) perform efficiently in viremic patients. Further refinements of these criteria [Expanded Baveno VI criteria (Plt110/LSM25), or Plt125/LSM25 criteria] maintain high accuracy sparing more endoscopies. The Plt150/MELD6 criteria are less accurate in viremic cACLD patients. How sustained virological response (SVR) achieved by direct-acting antivirals (DAA) impacts on such criteria is unknown. We assessed the performance of Expanded Baveno VI, Plt125/LSM25 and PLT150/MELD6 criteria, compared to the original Baveno VI criteria, to rule out HRV in 192 HCV-related cACLD patients with an SVR to DAAs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
